Is adding ribociclib to fulvestrant cost-effective in treating postmenopausal women with HR+/HER2- advanced or metastatic breast cancer? A US payer perspective cost utility analysi...

por Berrios, Kevin, Burum, Alexandra, Jeong, Eunae, Zhong, Lixian
Publicado 2022

Cost-Effectiveness of Adding Ribociclib to Endocrine Therapy for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Among Premenopausal or Perimenopausal Women

por Jeong, Eunae, Wang, Changjun, Wilson, Leslie, Zhong, Lixian
Publicado 2021

Migraine and Medical Ramifications: A Comprehensive Overview Based on Observational Study Meta-Analyses

por Chen, Weiwei, Qian, Wenqi, Zhong, Lixian, Jing, Gongwei
Publicado 2021

Egg Laying Decisions in Drosophila Are Consistent with Foraging Costs of Larval Progeny

por Schwartz, Nicholas U., Zhong, Lixian, Bellemer, Andrew, Tracey, W. Daniel
Publicado 2012

Early warning and monitoring of COVID-19 using the Baidu Search Index in China

por Zhou, Wanwan, Zhong, Lixian, Tang, Xiaofen, Huang, Tengda, Xie, Yihong
Publicado 2022

Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer

por Zhong, Lixian, Tran, Anh Thu, Tomasino, Taylor, Nugent, Elizabeth, Smith, Judith A.
Publicado 2018

Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems

por Tang, Jun, Zhong, Lixian, Paoli, Carly, Paciorek, Alan, Carroll, Peter, Wilson, Leslie
Publicado 2019

Impact of a pharmaceutical care incentive program on the asthma medication ratio among pediatric patients with persistent asthma enrolled in a Medicaid program

por Hernández-Muñoz, José J, Kamdar, Chandni R, Zhong, Lixian, Alonzo, Joy, Sprenger, Lisa
Publicado 2021

Effectiveness and economic impact of a diabetes education program among adults with type 2 diabetes in South Texas

por Smith, Matthew Lee, Zhong, Lixian, Lee, Shinduk, Towne, Samuel D., Ory, Marcia G.
Publicado 2021

Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses

por Zhong, Lixian, Wu, Chutian, Li, Yuting, Zeng, Qiuting, Lai, Leizhen, Chen, Sisi, Tang, Shaohui
Publicado 2022

Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA

por Ionova, Yelena, Vuong, Wilson, Sandoval, Omar, Fong, Jodie, Vu, Vincent, Zhong, Lixian, Wilson, Leslie
Publicado 2022

Psoriasis and medical ramifications: A comprehensive analysis based on observational meta-analyses

por Zhou, Yun, Zhong, Lixian, Shen, Lianli, Chen, Sisi, Zeng, Qiuting, Lai, Leizhen, Tang, Shaohui
Publicado 2022

Effectiveness of the Program to Encourage Active, Rewarding Lives (PEARLS) to reduce depression: a multi-state evaluation

por Smith, Matthew Lee, Steinman, Lesley E., Montoya, Carol N., Thompson, Meghan, Zhong, Lixian, Merianos, Ashley L.
Publicado 2023

External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations

por Silva, Patrick, Janjan, Nora, Ramos, Kenneth S., Udeani, George, Zhong, Lixian, Ory, Marcia G., Smith, Matthew Lee
Publicado 2023

Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer

por Le, Vivian, Zhong, Lixian, Narsipur, NihaL, Hays, Elizabeth, Tran, Daniel Khuong, Rosario, Kimberly, Wilson, Leslie
Publicado 2021

Cost-effectiveness of adding daratumumab or bortezomib to lenalidomide plus dexamethasone for newly diagnosed multiple myeloma

por Narsipur, Nihal, Bulla, Sabrina, Yoo, Connie, Do, Brenda, Tran, Kyle, Gu, Dian, Zhong, Lixian, Wilson, Leslie
Publicado 2021

Cost–Utility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels

por Weng, Xiuhua, Luo, Shaohong, Lin, Shen, Zhong, Lixian, Li, Meiyue, Xin, Rao, Huang, Pinfang, Xu, Xiongwei
Publicado 2020

Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies

por Zhong, Lixian, Chen, Weiwei, Wang, Tonghua, Zeng, Qiuting, Lai, Leizhen, Lai, Junlong, Lin, Junqin, Tang, Shaohui
Publicado 2022

Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis

por Zhong, Lixian, Pon, Vickie, Srinivas, Sandy, Nguyen, Nicole, Frear, Meghan, Kwon, Sherry, Gong, Cynthia, Malmstrom, Robert, Wilson, Leslie
Publicado 2013

Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial

por Peng, Xiaojuan, Chen, Sisi, Zhong, Lu, Li, Yuting, Wu, Chutian, Zhong, Lixian, Chen, Weiwei, Yang, Jinying, Zeng, Jiahua, Tang, Shaohui
Publicado 2023